Julia Lainster

Julia Lainster

HealthTech Solutions Expert
Julia Lainster is an expert in Healthtech with a focus on electronic health records, interoperability standards, and cybersecurity. Her content is geared toward industry leaders and organizations seeking to leverage technology to improve efficiency, accuracy, and security in healthcare delivery. Julia aims to drive digital transformation and innovation in Healthtech.
Review of Cannabis for Chronic Pain
Research & Development Review of Cannabis for Chronic Pain

The relentless pursuit of effective chronic pain management has led millions of people down a path lined with cannabis products, each promising a definitive end to their suffering. As legalization expands and access grows, cannabis has transitioned from a fringe substance to a mainstream wellness

AI Predicts Blood Loss to Improve Liposuction Safety
Tech & Innovation AI Predicts Blood Loss to Improve Liposuction Safety

The world's most popular cosmetic surgery now has a digital guardian, an intelligent algorithm designed to foresee its most significant complication before it even begins. Liposuction, a procedure sought by millions for aesthetic enhancement, carries inherent surgical risks that scale with the

Engineered Extracellular Vesicles – Review
Research & Development Engineered Extracellular Vesicles – Review

The intricate challenge of retraining the immune system to tolerate specific self-antigens without compromising its protective capabilities has driven the development of highly sophisticated therapeutic platforms. The emergence of engineered extracellular vesicles (EVs) represents a significant

Could a New Enzyme Be the Key to Weight Loss?
Research & Development Could a New Enzyme Be the Key to Weight Loss?

The intricate web of biochemical signals governing the body's fat storage mechanisms has long presented a formidable challenge to medical science, but a recent discovery may have untangled a critical thread. Research has unveiled a previously unknown enzyme that acts as a master switch for fat

Is Alzheimer's Disease Actually Reversible?
Research & Development Is Alzheimer's Disease Actually Reversible?

For over a century, Alzheimer's disease has been seen as an irreversible decline, a one-way street of cognitive loss. But what if the brain holds the capacity to repair itself, even from advanced stages of the disease? Recent findings have challenged this long-held dogma, suggesting that restoring

Wearable AI Detects Early Signs of Frailty
Tech & Innovation Wearable AI Detects Early Signs of Frailty

A pioneering development in geriatric medicine from the University of Arizona's Gutruf Lab has unveiled an advanced wearable device that employs artificial intelligence to proactively identify the earliest indicators of frailty in older adults. This groundbreaking technology represents a

Can This Model Stop Late-Stage Cancer in Africa?
Tech & Innovation Can This Model Stop Late-Stage Cancer in Africa?

In a region where a colorectal cancer diagnosis is often synonymous with a grim prognosis due to late detection, a groundbreaking pilot program in Osun State, Nigeria, has ignited new hope. With roughly 80% of patients in the country typically diagnosed at an advanced stage, the disease has

Study Reveals How SARS-CoV-2 Manipulates Host RNA
Tech & Innovation Study Reveals How SARS-CoV-2 Manipulates Host RNA

Today, we're joined by Ivan Kairatov, a leading biopharma expert whose recent work has uncovered a startling new mechanism used by SARS-CoV-2. His team's research reveals how the virus doesn't just evade the immune system but actively commandeers the host's cellular machinery in a way never before

Can a Split Verdict Save Galapagos's Future?
Research & Development Can a Split Verdict Save Galapagos's Future?

The delicate balance of pharmaceutical innovation often hinges on a single set of clinical data, and for the Belgian biotech firm Galapagos, the recent trial results for its experimental drug GLPG3667 have created a narrative of both triumph and tribulation. This TYK2 inhibitor, designed to quell

Can a US-Japan Partnership Reshape Drug Discovery?
Research & Development Can a US-Japan Partnership Reshape Drug Discovery?

In an industry where the path from laboratory concept to patient bedside is often decades long and costs billions, the traditional, siloed approach to research and development is proving increasingly insufficient for tackling today's complex medical challenges. A new paradigm of "open innovation"

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later